36E79725R0024_1.docx

DOCX document 17 KB Posted

Attached to
6505--Buspirone RFP Federal contract opportunity
Solicitation number
36E79725R0024
Issued by
Department of Veterans Affairs National Acquisition Center

About this file

This is a Pre-Solicitation Notice for a Request for Proposal (RFP) by the VA National Acquisition Center for Buspirone HCL Tablets. The solicitation (36E79725R0024) is an unrestricted procurement for multiple federal agencies including the Department of Veterans Affairs (VA), Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The VA plans to award a single contract for a one-year base period with four additional one-year option periods, distributing items through VA and DOD Pharmaceutical Prime Vendor Programs.

The solicitation covers multiple Buspirone HCL tablet strengths and bottle sizes, with substantial estimated annual requirements ranging from 4,390 to 179,623 bottles across different dosages (5mg, 7.5mg, 10mg, 15mg, and 30mg). Key requirements include providing the exact drug name as it appears on the label, having a unique NDC number, and using child-resistant closures for bottles of 100 tablets or less. The solicitation will be electronically issued on or about 04/08/2025, with a tentative closing date of April 22, 2025. Interested offerors should check http://www.sam.gov for updates, and can direct questions to Amber Zavala at amber.zavala@va.gov.

View the file

On GovTribe

Work with this file on GovTribe

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

SUBJECT*

Buspirone RFP

GENERAL INFORMATION

CONTRACTING OFFICE’S ZIP CODE*
60141
SOLICITATION NUMBER*
36E79725R0024
RESPONSE DATE/TIME/ZONE
04-23-2025 2:30PM CENTRAL TIME, CHICAGO, USA
ARCHIVE
99 DAYS AFTER THE RESPONSE DATE

SET-ASIDE

PRODUCT SERVICE CODE*
6505
NAICS CODE*
325412

PLACE OF PERFORMANCE

POSTAL CODE

COUNTRY

CONTACT INFORMATION

CONTRACTING OFFICE ADDRESS

POINT OF CONTACT*

Amber Zavala Amber.Zavala@va.gov amber.zavala@va.gov

(708) 786-5245

ADDITIONAL INFORMATION

AGENCY’S URL

URL DESCRIPTION

AGENCY CONTACT’S EMAIL ADDRESS

EMAIL DESCRIPTION

Presolicitation Notice Presolicitation Notice

DESCRIPTION

*=Required Field
Presolicitation Notice

Presolicitation Notice

PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue a Request for Proposal (RFP) 36E79725R0024 for an unrestricted procurement for Buspirone HCL Tablets, for the Department of Veterans Affairs (VA), Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA’s and DOD’s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have a unique NDC number. All bottles of 100 tablets or less must have a child resistant closure. Glass bottles are not acceptable. Solicitation # 36E79725R0024 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about 04/08/2025 with a tentative closing date of April 22, 2025. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: http://www.sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Amber Zavala. Questions can be e-mailed to: amber.zavala@va.gov.

The estimated annual requirements are as follows:

Description Size Estimated Annual Requirements (Bottles)

BUSPIRONE HCL 10MG TAB 100 7,928

BUSPIRONE HCL 10MG TAB 500 179,623

BUSPIRONE HCL 15MG TAB 60 158,668

BUSPIRONE HCL 15MG TAB 500 74,023

BUSPIRONE HCL 30MG TAB 60 68,811

BUSPIRONE HCL 5MG TAB 100 4,390

BUSPIRONE HCL 5MG TAB 500 51,086

BUSPIRONE HCL 7.5MG TAB 100 42,775

File details come from the government source that posted it. Updated .